Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

Psychostimulants, including amphetamines and methylphenidate, are first-line
pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD). This …

We performed a scientometric analysis of the scientific literature on ADHD to evaluate key
themes and trends over the past decades, informing future lines of research. We conducted …

Abstract Attention-Deficit/Hyperactivity Disorder (ADHD), although considered a childhood-
onset neurodevelopmental condition, is nevertheless a frequent and disabling condition in …

The aim of this study is to gather evidence of head-to-head double-blind randomized-
controlled trials on the efficacy and safety of available treatments for attention deficit …

Recent studies highlight the role of excessive mind wandering in attention-
deficit/hyperactivity disorder (ADHD) and its association with impairment. We believe …

The spontaneously hypertensive rats (SHR) are the most widely used model for ADHD.
While face and construct validity are consolidated, questions remain about the predictive …

Background The efficacy of meditation-based therapies for attention deficit/hyperactivity
disorder (ADHD) across the lifespan remains uncertain. Objective To conduct a systematic …

The publication of our updated network meta-analysis1 about antidepressants for the acute
treatment of major depression has generated a wide discussion in newspapers, 2, 3 social …

Since the landmark MTA (Multimodal Treatment of ADHD) trial unequivocally demonstrated
the efficacy of methylphenidate, catecholaminergic drugs, especially stimulants, have been …